Biotechnology and Pharmaceutical

The biotechnology and pharmaceutical sectors face constant challenges – legal, regulatory, commercial and financial. Thomson Geer's specialist lawyers understand and advise on the wide range of issues facing this complex and highly regulated industry.

Our in depth knowledge covers human and animal health markets, medicine and device industries and across the complete life cycle of biotechnology, pharmaceutical and device products. We work closely with our clients to add value and help them to maximise their success, protect against risk and maximise their achievements.

Clients in this industry include start-up companies, venture capital investors, spin off companies, private and publicly listed entities, government, research institutes, leading universities, manufacturers and distributors, international trial sponsors, contract research organisations, collaborative research groups, institutions and principal investigators, biotechnology, medical device and pharmaceutical organisations.

We are the trusted advisors to our clients in this sector, helping them to navigate everything from complex transactions and licensing / collaboration deals to their day to day operational needs to achieve their desired outcome.

Licensing and partnering

‍
The biotech and pharma sector often involves researchers and companies working together to bring discoveries and drugs to the market. When this happens, they require agreements that lay out what all sides have to do. Our lawyers have experience establishing marketing agreements, commercialisation licences, collaboration and research agreements, joint ventures and term sheets, memorandums of understanding and heads of agreement.

Regulatory issues

‍

The biotech and pharma sector is highly regulated. Our team help clients to navigate laws and regulators such as the Therapeutic Goods Administration. We assist on issues such as labelling, approvals for therapeutic and non-therapeutic goods, medical devices and clinical trials.

Capital raising

‍
Our lawyers have extensive experience helping biotech companies to raise funds by listing on the share market through an initial public offering. They can also advise on raising funds through private equity and angel investors, as well as applying for funding grants.

Clinical trials

‍
We advise on the conduct of clinical trials, including sponsorship arrangements, compliance with HREC (human research ethics committee) rules, investigator led trials, and trial participant issues such as privacy.

Intellectual property

‍
Our Intellectual Property team can assist with protecting your valuable intellectual property.

Corporate structuring and collaborations‍

‍
Thomson Geer's lawyers advise on all aspects of commercial and corporate law and regulation, including structuring and taxation matters. We help clients ensure their company structures are most appropriate for achieving their ultimate goals. We also work with clients to create research collaborations, from study specific through to long term collaborations involving the creation of new medical research institutes.